Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clonal cytotoxic T cells in myeloma.

Leukemia & lymphoma - 1 Oct 2003

Sze Daniel M Y, Brown Ross D, Yuen Edna, Gibson John, Ho Joy, Raitakari Maria, Basten Antony, Joshua Douglas E, Fazekas de St Groth Barbara

Abstract excerpt

Multiple myeloma (MM) is a malignant disease characterized by accumulation of morphologically recognizable plasma cells producing immunoglobulin (Ig) in the bone marrow. The occurrence of clonal T cells in MM, as defined by the presence of rearrangements in the T-cell receptor (TCR)-beta chains detected on Southern blotting, is associated with an improved prognosis. This review aims to describe the various ways...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Clone Cells
Share to Forecasting

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Rearrangement, beta-Chain T-Cell Antigen Receptor

Share to Multiple Myeloma

Share to Phenotype

Share to Receptors, Antigen, T-Cell

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 14692517
DOI: 10.1080/1042819031000097438

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clonal cytotoxic T cells in myeloma.PMID 14692517Read ↗

T‐cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cellsSemantic proximity Read ↗

Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.Semantic proximity Read ↗

Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and ResistanceSemantic proximity Read ↗

Expansion of immunoglobulin autoreactive T-helper cells in multiple myeloma.Semantic proximity Read ↗

Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies.Semantic proximity Read ↗

Severe and long‐lasting disruption of T‐cell receptor diversity in human myeloma after high‐dose chemotherapy and autologous peripheral blood progenitor cell infusionSemantic proximity Read ↗

Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma.Semantic proximity Read ↗

Immunoglobulin gene rearrangements and the pathogenesis of multiple myelomaSemantic proximity Read ↗

Sequential phenotyping of myeloma patients on chemotherapy: persistence of activated T-cells and natural killer cells.Semantic proximity Read ↗

Ig gene sequences in the study of clonality.Semantic proximity Read ↗

CD8+T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burdenSemantic proximity Read ↗

T-cell antigen-positive multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.